An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
Dr. Federica Gatti
Advertisement
Gatti is a medical oncologist at the Regina Elena National Cancer Institute in Rome, Italy.
Articles by Dr. Federica Gatti
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
2
Psychiatrist Answers Questions About Family and Relationships During Cancer
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
Finding My Rhythm Again: What Fall Means to Me After Cancer
5